TKT and neoplasm: The commonly used safety switches — herpes simplex virus thymidine kinase (HSV-TK) (2), inducible caspase 9 (iCasp) (3), and the CD20/rituximab system (4) — typically induce a tolerogenic form of cell death that may lead to an immunosuppressive tumor microenvironment (TME) (5).